Experts warn that commercial incentives like this one create conflicts of interest that could impact patient autonomy. 2/2

Marketing experimental technologies to make “better babies” as good investments for parents and for the country repackages early 20th century eugenic beliefs that controlling reproduction will improve humanity. 3/3 www.geneticsandsocie...

The technical challenges, safety risks, and significant ethical concerns posed by embryo editing techniques underscore that it should not be considered for commercial application.
2/3

A growing coalition of organizations and individuals concerned about designer babies and a techno-eugenic future has signed on to an international declaration against the legalization of human genetic modification. You can sign it here: coalitionstopdesigne...

Another flavor of pronatalism spurs Silicon Valley's interest in gene editing human embryos. Eager to create a world of genetic haves and have-nots, they ignore near-global policy consensus against HGE and dismiss concerns abt the techno-eugenic future they could usher in.2/3

To counter harmful pronatalist logics and their application in policy and new biotechnologies, Black feminists and allies recently gathered at a convening at Smith and Amherst Colleges to update the reproductive justice framework created by Black feminists in the 1990s. 2/2 msmagazine.com/2025/...

We need an emphatic rejection of eugenic logics and strong regulation based in social justice values to prevent the use of risky and unethical techniques like heritable genome editing. 7/7

CGS’ Katie Hasson warned of this “new eugenics gold rush” in August, “If ‘better babies’ (for those who can afford them) become a profit center, techno-eugenics – and assumptions about superiority based on genes – will take off.” 6/7
www.geneticsandsociety.org/biopolitical...

Scientists, bioethicists, and civil society continue to raise alarms. These risky ventures are speeding past significant safety and ethical risks in an attempt to profit from gene editing embryos. 5/7 www.nature.com/articles/d41...

Gene editing scientist Lucas Harrington announced that his company, Preventive, has $30M in funding to research heritable genome editing. Their eventual goal: making embryo editing a commonplace technology. 4/7
www.technologyreview.com/2025/10/31/1...

One startup, Manhattan Genomics, is undeterred by risks of editing human embryos and prohibitions in place. Its founder, former Thiel fellow Cathy Tie, announced a slate of advisors recruited to guide the project, which she says only aims to correct genetic diseases.3/7 www.wired.com/story/startu...

Just this past week, two new startups announced their efforts to advance heritable genome editing – despite immense risks, widespread opposition, and laws that prohibit it. 2/7

Its human-oriented efforts are likely to receive ethical scrutiny, just as its de-extinction efforts have.